chrisvoncsefalvay/vaers-outcomes huggingface dataset:
He has had a series of 3 shots. Second dose 07/17/2012, last one given: 01/09/13. He began to experience light headedness and dizziness after the first shot. It was happening off an on. By the third shot, he had been continuously sick with fatigue, headaches, blurry vision off an on. After many weeks of tests due to his symptoms, they found strep bacteria in his blood. Gave him a round of antibiotics. We saw an infectious disease doctor to rule out rheumatic fever which we did. He began to get stretch marks all over his body that look like the bartonella rash on his lower back, sides and shoulders. He still has them and is 16. He still experiences numbness and tingling sensations. Has stated numerous times that he has a feeling of fogginess in his head after receiving the vaccines. I requested doxycycline for him for acne. I later learned that this is an antibiotic that is sometimes used to help with bartonella. I am thinking this is why his symptoms may have stabilized instead of progressed. I am not certain that the health issues are due to the HPV vaccine, but since these symptoms began after the first shot, looking back on the situation, I feel the vaccine may have played a part in it. His grades in school changed at that time, and his memory and cognitive function changed. I feel it is worth mentioning because it is coincidental.
Chills, fever, headache, muscle ache, joint ache, tingling arm, nausea
Site: Itching at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Additional Details: patient recieved Prevnar 20 on March 26, 2022. Patient came in to pharmacy to show she have developed redmess about 4 inches by 4 inches size also itchy. She stated that she has been watching it and it a bit better. I advice her to see her primary care doctor if she is not much better in a few days.
Information has been received from a registered nurse (R.N) concerning a 52 year old male patient who on 08-OCT-2010 was vaccinated into his right deltoid with a 0.5mL dose of PNEUMOVAX 23 (lot  number unknown). The nurse stated that on 11-OCT-2010 the patient was seen at the doctor's office with pain and swelling at the injection site. He also had a previous appointment scheduled for non related blood work on 13-OCT-2010 and was examined by the nurse on that day too. At the time of report, the patient's outcome was unknown. Follow up information has been received from the nurse who stated that she would report back with the lot information if it were available. A lot check has been initiated. All telephone attempts to obtain follow up information have been unsuccessful. This is one of several reports from the same source. Additional information has been requested. Follow-up information received via telephone call from the registered nurse who indicated that the lot 3 of PNEUMOVAX 23 was 664653/1307Y and expiration date was 03-MAR-2011. Additional information is not expected.
Client described headache that started immediately, light sensitivity in Right eye; on 3/28/2016 started experiencing stiff neck and "pin prick feeling" in fingers and lips.
Redness/swelling at injection site. Reports feeling general malaise, body aches and fever of 102 within hours of vaccination. Fever gone 24 hrs. later. Feeling better today. Area of redness is not increasing in size.
Hx of COVID-19 twice, last time sx's started 8/28/22 and dx'd 9/1/22.  Received first dose Moderna 9/8/22.  Second dose 2/23/23.  AvaYa27 Was seen 3/8/23 reporting anhedonia and decreased sex drive starting 4 days prior.  Since then has reported tinnitus, palpitations, and erectile dysfunction which have not improved since the vaccination.
PPSORIASIS FLARE UPS/PATCHES ON FACE, STOMACH AND ARMS; First Dose was adminstered on 31-Aug-2021 and Second Dose on 21-Sep-2021; This spontaneous case was reported by a patient and describes the occurrence of PSORIASIS (PPSORIASIS FLARE UPS/PATCHES ON FACE, STOMACH AND ARMS) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First Dose was adminstered on 31-Aug-2021 and Second Dose on 21-Sep-2021) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Plaque psoriasis.    Concurrent medical conditions included Plaque psoriasis.   On 31-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) Citrate Free. On 21-Sep-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First Dose was adminstered on 31-Aug-2021 and Second Dose on 21-Sep-2021). On an unknown date, the patient experienced PSORIASIS (PPSORIASIS FLARE UPS/PATCHES ON FACE, STOMACH AND ARMS). At the time of the report, PSORIASIS (PPSORIASIS FLARE UPS/PATCHES ON FACE, STOMACH AND ARMS) had not resolved and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First Dose was adminstered on 31-Aug-2021 and Second Dose on 21-Sep-2021) outcome was unknown. Not Provided    No relevant concomitant medications were reported.   The reporter's causality for the event of psoriasis flare ups/patches on face, stomach and arms with humira was not provided.  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  Primary reporter contact for lot number information was unsuccessful.  No treatment information was provided.
Fever, chills, deep muscle aches, vomiting, and then rapid pounding heart and fluttering sensation for approximately 1 minute at a time while in prone position in bed. Heart rate returned to normal, would periodically wake me up pounding so hard. Husband took me to the ER at approx 0600. Heart rate returned to normal.
vasculitis / prednisone, colchicine, TCA cream and dicloxacillin / still active
Sudden onset of flat red patches on face, red tartetoid plaques on hands, wrists and left extensor surface of elbow, palms included. tense bulla on left hand digit. Primarily affecting hands and face. Diagnosed as Erythema Multiforme Minor
On 10/19/00, the pt was hospitalized with pneumonia. The mother indicated that her physician stated there was not any relationship between the MMR vaccine and the development of pneumonia. No further information is available.
This spontaneous report as received from a healthcare worker refers to a 13 year old patient were vaccinated with a dose of GARDASIL (Lot#: 0459AE, expiration date: 13-DEC-2014) (dose, frequency, dose number and route were not reported). The patient was vaccinated with a dose of an improperly stored GARDASIL. No adverse effects reported. This is one of two reports received from the same reporter MARRS#: 1404USA005700. Additional information has been requested.
Over time after my third dose of the moderna i have developed, PVC's and start getting chest pains and feeling like I can't breathe, along with high heart rate.
she and her husband have both been "sick; not yet completed the 2 dose vaccine series; She administered it intramuscularly /  into his buttock; This case was reported by a nurse via call center representative and described the occurrence of sickness in a 72-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On 28th March 2020, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, the patient received the 2nd dose of Shingrix. On 28th March 2020, unknown after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced vaccine administered at inappropriate site. On an unknown date, the patient experienced sickness and incomplete course of vaccination. On an unknown date, the outcome of the sickness, vaccine administered at inappropriate site and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the sickness to be related to Shingrix.  Additional details were reported as follows: The case was reported by patient's wife who was a nurse. The reporter does not have a record of the lot/expiry details for the first dose. Nurse said that she was very experienced, and she had been a nurse for 45 years and had given thousands of shots. The patient received 1st dose of Shingrix (intramuscularly) and was administered into his buttock, which led to vaccine administered at inappropriate site. Till the time of reporting, the patient had not yet completed the 2 dose of Shingrix vaccine series as the nurse did not had another vial of adjuvant to prepare a dose for patient, which led to incomplete course of vaccination.  Nurse stated that the patient had been sick recently. The reporter did not ask for MD contact information. This case had been linked with US2020AMR206531 and US2020204772, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR206531:Wife's case US-GLAXOSMITHKLINE-US2020204772:Wife's case
Urticaria, no respiratory symptoms. Pt given 20 mg of IM Diphenhydramine, monitored until almost complete resolution of urticaria. Discharge to home.
Pt experienced difficulty breathing/swallowing, numbness/tingling in left foot, lightheadedness and chest pain/tightness 30 minutes following vaccination. Pt states that symptoms have persisted intermittently since receiving vaccine.
Severe weakness and dizziness started within 30 minutes after injection, lasted 3 days, treated by bedrest, fluids, and Tylenol.
Headache; Nausea; Vomiting; Diarrhea; I just ache all over; This is a spontaneous report from a contactable consumer (patient). A 61-year-old female patient received bnt162b2 (Pfizer-BioNTech COVID-19 mRNA vaccine; Solution for injection; lot number: EJ1685; expiration date: not known), via an unspecified route of administration on 29Dec2020 at single dose for covid-19 immunisation. Medical history included hypertension. The patient's concomitant medications were not reported. The patient had been feeling fine after her last vaccination when she took it at a hospital on 29Dec2020 until today (01Jan2021), in which she experienced headache, nausea, vomiting, diarrhea, and she just ache all over. The patient stated it was not serious and just wanted to make sure she was not supposed to be doing something. The patient did not receive treatment for these reported events. The outcome of the events was unknown.
Patient reports being lethargic, with chills and a "parkinson's like" shiver that was unrelated to the chills she experienced. She reported having muscle aches for 2 days following vaccination in her back and arms. She also experienced arm 'twitching'. Patient states she had a mild fever but no nasal activity (runny nose, etc.), lungs felt fine, no cough. Patient also reports she hasn't been sick in a while.
I developed a breakthrough Covid on 5/24/22. My physician prescribed Paxlovid which I took for 5 days. I tested negative on 5/31/22..
47 Days post first vaccine and have not received the second vaccine; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (47 Days post first vaccine and have not received the second vaccine) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.).    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (47 Days post first vaccine and have not received the second vaccine). On 16-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (47 Days post first vaccine and have not received the second vaccine) had resolved. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided. Concomitant medication were not provided. The reporter states that the patient took the second dose vaccine    Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: Significant Follow up- patient received 2nd dose and no AE reported; Reporter's Comments: This report refers to a case of Inappropriate schedule of product administration for mRNA-1273, lot# 042L20A, with no associated adverse events.
Mild Cough; Achy Body; Sneezing; Head Congestion; Low Grade Fever; Sore Arm; Headache; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Mild Cough), MYALGIA (Achy Body), SNEEZING (Sneezing), HEAD DISCOMFORT (Head Congestion) and VACCINATION SITE PAIN (Sore Arm) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced VACCINATION SITE PAIN (Sore Arm), HEADACHE (Headache) and FATIGUE (Fatigue). On 17-Jan-2021, the patient experienced COUGH (Mild Cough), MYALGIA (Achy Body), SNEEZING (Sneezing), HEAD DISCOMFORT (Head Congestion) and PYREXIA (Low Grade Fever). On 10-Jan-2021, VACCINATION SITE PAIN (Sore Arm), HEADACHE (Headache) and FATIGUE (Fatigue) was resolving. On 20-Jan-2021, COUGH (Mild Cough), MYALGIA (Achy Body), SNEEZING (Sneezing), HEAD DISCOMFORT (Head Congestion) and PYREXIA (Low Grade Fever) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Jan-2021, SARS-CoV-2 antibody test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
FEVER, VOMITING, RASH, HEADACHE, SYMPTOMS X3 DAYS.  SEEN AGAIN ON 04/03/2008, CBC DONE, CHEST X- RAY DONE.
Patient experienced fevers of 101.3-101.4 with rash 4 days following administration of Hep A and flu vaccine. Parents gave Tylenol and Motrin for fever.
Site of injection is red and puffy. It started to occur one week after the injection was given and continues to the present time.
I experienced a very hyper heart rate. I was treated at the ER when I was out of town. I was given Diltiazem and my heart rate eventually started to go back to normal. I was diagnosed with atrial fibrillation with a rapid ventricular response. I also experienced shortness of breath and lightheadedness. On March 13, 2023 I visited my cardiologist. I was prescribed blood thinner Xarelto and my doctor doubled my dose of Metoprolol.
I experienced a breakthrough case of COVID-19 with congestion, coughing and fatigue.
Pt stated she was shaking, sharp abdominal pain, eyes burning, temperature of 100.4 F, nauseous, weak, near fainting, difficulty breathing, and burning knees.
DEVELOPED SEVERE NAUSEA DURING THE NIGHT OF THE SHOT, ONCE TO THE POINT OF VOMITING.  HAD A HEADACHE AND NO APPETITE THE FOLLOWING DAY.  NO FEVER.
Patient is a 41 y.o. female who presented to the ED with complaints of a reaction after she took the COVID vaccine.  Patient is an RN here and had earlier received COVID-19 vaccination (Moderna) around 0130 this afternoon. Soon after she experienced rash which was burning and itchy on her arms thighs and back. She reported to Occ health and was directed to the ED. While in the ED she experienced throat tightness and nausea. She had one episode of diarrhea.  No tongue, lip swelling, SOB or difficulty swallowing. Denies any chest pain, palpitations, pre-syncope/syncope.   No vomiting abdominal pain. H/o of allergy to fish mix and dust mite.
This case involves patient (unknown age and gender) who had extreme headache (headache), nausea, shivering (chills) and vomiting, after receiving MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] and MENINGOCOCCAL VACCINE B RFHBPA/FHBPB (TRUMENBA). It was unknown if the patient had any medical history, concomitant disease or risk factor. Medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided. On an unknown date, the patient received a dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE and dose of suspect TRUMENBA not produced by Sanofi Pasteur (lot number and expiration date were not reported) via unknown route in an unknown administration site for prophylactic vaccination. On an unknown date, the patient developed non-serious extreme headache (headache), nausea, shivering (chills) and vomiting, within one hour following the administration of vaccines. It was unknown if the patient experienced any additional symptoms/events. It was unknown if there were lab data/results available. The patient went to the emergency room (ER) and was administered ONDANSETRON (Zofran ) and IBUPROFEN as a corrective treatment.  The patient recovered from the reported events. There will be no information available on the batch number for this case.
Intense fasciculations and  spastic muscle contractions of bilateral anterior tibialis , distal bilateral hamstring fasiculations (right greater than left, neck rigidity and nuchal /low occipital headaches.  Treated initially with 2000mg acetaminophen and 660mg naprosyn per day, warm compresses to neck, walking and cervical traction.  After several weeks the symptoms diminished but continued and MRI's of back and neck were done and showed some chronic degenerative changes. EMG was abnormal with signs of radiculopathy in the lumbar back and peripheral neuropathy, but similar to findings 3 years earlier.  A trial of Medrol 20mg and tapering off in 8 days showed significant improvement in the muscle cramping and fasiculations. Improvement was maintained for 7-8 days after stopping the Medrol but returning gradually over the next 7-10 days but at about 60-70% of the level prior to the Medrol.
Thinks got the vaccine subcutaneously; Drip of the vaccine came out of injection site; Hard lump at injection site; elevated temperature 98.4; Pain at injection site; Swollen at injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Thinks got the vaccine subcutaneously), ACCIDENTAL UNDERDOSE (Drip of the vaccine came out of injection site), VACCINATION SITE MASS (Hard lump at injection site), BODY TEMPERATURE INCREASED (elevated temperature 98.4) and VACCINATION SITE PAIN (Pain at injection site) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported. ). Concomitant products included ESTRIOL, BIFIDOBACTERIUM LONGUM, LACTOBACILLUS ACIDOPHILUS, LACTOBACILLUS RHAMNOSUS (PROBIOTICS [BIFIDOBACTERIUM LONGUM;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS RHAMNOSUS]) and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Thinks got the vaccine subcutaneously), ACCIDENTAL UNDERDOSE (Drip of the vaccine came out of injection site), VACCINATION SITE MASS (Hard lump at injection site), BODY TEMPERATURE INCREASED (elevated temperature 98.4), VACCINATION SITE PAIN (Pain at injection site) and VACCINATION SITE SWELLING (Swollen at injection site). On 11-Mar-2021, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Thinks got the vaccine subcutaneously) and ACCIDENTAL UNDERDOSE (Drip of the vaccine came out of injection site) had resolved. At the time of the report, VACCINATION SITE MASS (Hard lump at injection site), BODY TEMPERATURE INCREASED (elevated temperature 98.4), VACCINATION SITE PAIN (Pain at injection site) and VACCINATION SITE SWELLING (Swollen at injection site) outcome was unknown.            Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Headaches; Nausea; Fatigue; Sore Arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore Arm), HEADACHE (Headaches), NAUSEA (Nausea) and FATIGUE (Fatigue) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore Arm). On 03-Mar-2021, the patient experienced HEADACHE (Headaches), NAUSEA (Nausea) and FATIGUE (Fatigue). On 28-Feb-2021, PAIN IN EXTREMITY (Sore Arm) had resolved. At the time of the report, HEADACHE (Headaches), NAUSEA (Nausea) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided. Concomitant medications were not provided.
administered using two different batches; administered using two different batches; This case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 2-month-old male patient who received Rota (Rotarix lyophilized formulation) (batch number M4AR7, expiry date 6th July 2023) and (batch number 5BC7N, expiry date 11th July 2022) for prophylaxis.   Co-suspect products included rotavirus vaccine oral applicator device (Rotarix Oral Applicator Device) oral applicator for prophylaxis.   On 22nd June 2022, the patient received Rotarix lyophilized formulation. On an unknown date, the dose was an unknown dose. On 22nd June 2022, the patient started Rotarix Oral Applicator Device. On 22nd June 2022, unknown after receiving Rotarix lyophilized formulation and Rotarix Oral Applicator Device, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 22-June-2022 Reporter's comment: A nurse reported that the Rotarix vaccine was administered to a patient using an approved diluent from a batch with a powder of another batch of Rotarix. The reporter consented to follow-up. Additional supportive information: The patient received the Rotarix vaccine which was reconstituted using two different batches of Rotarix vaccine, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.
HEADACHE 5 HOURS AFTER INJECTION. BODY ACHES AND REDNESS AROUND RIGHT ELBOW FOR ABOUT A WEEK.
pt devel gen body rash w/itching, raised welts relieved w/DPH & calamine lotion 9hr p/vax;
Patient with onset erythema, edema and warmth on right upper arm 24 hours after Dtap.
foot, ankle pain, calf pain, burning stinging radiating up my right side to my hip and lower back a blister broke out on my right hip shortly after the pain started, approximately around 1-5-2021, not sure of the exact date.
Patient states blistering on arm approximately 1 inch long and raised about 1/2 inch. She reports no fever, slight achiness throughout the day.
Unresponsive,  Tachycardia, Low bp, Temp 104 (sent to Er)